Tasly Pharmaceutical Group's low P/E ratio may reflect limit...
Tasly Pharmaceutical Group's low P/E ratio may reflect limited future growth expectations. Shareholders accept this, acknowledging future earnings may not surprise positively. Unless conditions improve, this will continue to limit the share price.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000021295dd9b35021.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment